Mj. Flens et al., IDENTIFICATION OF NOVEL DRUG RESISTANCE-ASSOCIATED PROTEINS BY A PANEL OF RAT MONOCLONAL-ANTIBODIES, International journal of cancer, 73(2), 1997, pp. 249-257
Since some multidrug-resistant (MDR) tumor cell lines show drug accumu
lation defects but do not over-express Pgp or MDR protein (MRP), a sea
rch was made for novel MDR-related transporter proteins by immunizing
rats with nonsmall cell lung cancer SW-1573/2R120 cells to produce mon
oclonal antibodies (MAbs). Five rat MAbs (LMR-4, -12, -42, -44 and -94
) were generated, showing strong membranous staining of non-Pgp MDR SW
-1573/2R120 tumor cells and minimal reactivity to the corresponding pa
rental and revertant cell lines. In addition, a 6th MAb (LMR-5) was is
olated, recognizing the MDR-related lung resistance protein (LRP), pre
viously identified as the major vault protein. The first 5 LMR MAbs sh
ow predominantly membranous staining of several non-Pgp MDR tumor cell
lines of different histogenetic origins, except for LMR-4, which reco
gnizes only MDR sublines of the SW-1573 cell line. Flow-cytometric ana
lysis revealed that all MAbs, except LMR-4 and -5, detect outside epit
opes. Functional studies showed that these MAbs did not restore the da
unorubicin accumulation defect. All but one of the MAbs (LMR-42) showe
d staining of distinct normal human tissues, notably epithelial cells
lining the airways and digestive tract. In addition, staining of vascu
lar endothelial cells was found with all MAbs except LMR-4, Three MAbs
(LMR-I2, -44 and -94) showed remarkable immunoreactivity with vincris
tine-selected SW-1573 sublines. By immunoblotting and precipitation, t
he LMR antigens were found to be in the 42-69 kDa range. (C) 1997 Wile
y-Liss, Inc.